Imoigele Aisiku - 23 Mar 2026 Form 4 Insider Report for VSEE HEALTH, INC. (VSEE)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
24 Mar 2026, 16:35:09 UTC
Prior SEC filing
19 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Imoigele Aisiku

Key filing fact

Imoigele Aisiku filed Form 4 for VSEE HEALTH, INC. (VSEE) on 24 Mar 2026.

Key facts

  • This page summarizes Imoigele Aisiku's Form 4 filing for VSEE HEALTH, INC. (VSEE).
  • 4 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 24 Mar 2026, 16:35.

Change

  • Previous filing in this sequence was filed on 19 Feb 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002026054 Primary reporting owner

Aisiku Imoigele

Relationship
Co-Chief Executive Officer, Director
Address
C/O VSEE HEALTH, INC., 980 N FEDERAL HWY #304, BOCA RATON
Signature
/s/ Imoigele Aisiku
Signature date
24 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VSEE transaction

Common Stock, par value $0.0001 per share

Award

Transaction value
Shares
+128,342
Change %
+3.8%
Price
$0.3700*
Shares after
3,545,031
Date
23 Mar 2026
Ownership
Direct
Footnotes
F1
VSEE transaction

Common Stock, par value $0.0001 per share

Award

Transaction value
Shares
+78,689
Change %
+2.4%
Price
$0.6100*
Shares after
3,416,689
Date
23 Mar 2026
Ownership
Direct
Footnotes
F2
VSEE transaction

Common Stock, par value $0.0001 per share

Award

Transaction value
Shares
+41,379
Change %
+1.3%
Price
$1.16*
Shares after
3,338,000
Date
23 Mar 2026
Ownership
Direct
Footnotes
F3
VSEE transaction

Common Stock, par value $0.0001 per share

Award

Transaction value
Shares
+40,000
Change %
+1.2%
Price
$1.20*
Shares after
3,296,621
Date
23 Mar 2026
Ownership
Direct
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Reflects shares of common stock issued to the reporting person under the issuer's 2024 Incentive Plan (the "Incentive Plan") as the quarterly equity award owed by the issuer to the reporting person for the quarter ended December 31, 2025 pursuant to the Executive Employment Agreement between the reporting person and the issuer dated December 10, 2025 (the "Employment Agreement"). The number of shares issued to the reporting person is based on the closing price of the common stock on December 31, 2025.

Footnote F2

Reflects shares of common stock issued to the reporting person under the Incentive Plan as the quarterly equity award owed by the issuer to the reporting person for the quarter ended September 30, 2025 pursuant to the Employment Agreement. The number of shares issued to the reporting person is based on the closing price of the common stock on September 30, 2025.

Footnote F3

Reflects shares of common stock issued to the reporting person under the Incentive Plan as the quarterly equity award owed by the issuer to the reporting person for the quarter ended June 30, 2025 pursuant to the Employment Agreement. The number of shares issued to the reporting person is based on the closing price of the common stock on June 30, 2025.

Footnote F4

Reflects shares of common stock issued to the reporting person under the Incentive Plan as the quarterly equity award owed by the issuer to the reporting person for the quarter ended March 31, 2025 pursuant to the Employment Agreement. The number of shares issued to the reporting person is based on the closing price of the common stock on March 31, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .